Page last updated: 2024-10-27

gemfibrozil and Lung Neoplasms

gemfibrozil has been researched along with Lung Neoplasms in 1 studies

Lung Neoplasms: Tumors or cancer of the LUNG.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tugnait, M1
Gupta, N1
Hanley, MJ1
Sonnichsen, D1
Kerstein, D1
Dorer, DJ1
Venkatakrishnan, K1
Narasimhan, N1

Trials

1 trial available for gemfibrozil and Lung Neoplasms

ArticleYear
Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers.
    Clinical pharmacology in drug development, 2020, Volume: 9, Issue:2

    Topics: Administration, Oral; Adult; Aged; Anaplastic Lymphoma Kinase; Area Under Curve; Carcinoma, Non-Smal

2020